Skip to main content
. 2019 Mar 19;10(4):268. doi: 10.1038/s41419-019-1505-5

Fig. 1.

Fig. 1

Schematic representation of activated signaling cascades in GSCs following treatment with SM; NF-kB activation promotes an autocrine/paracrine TNFα/IL6 signaling which in turn activates AKT/EZH2 and STAT3, consequently promoting self-renewal and therapeutic resistance. On the other hand, the combination of SM with EZH2 inhibitors results in cell death and GSCs depletion